• Optimi Health priced an oversubscribed underwritten public offering of 2,400,000 common shares at USD 6.25 each, targeting gross proceeds of about USD 15 million.
• The underwriter received an option to buy up to 360,000 additional common shares.
• Shares are expected to begin trading on the Nasdaq Capital Market under the symbol OPTH on May 20, 2026.
• The offering is expected to close on or about May 21, 2026, subject to customary conditions.
• Net proceeds are slated for scaling production and distribution, market expansion including the U.S., sales growth, working capital, and operating expenses.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Optimi Health Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202605200800NEWSFILECNPR____20260520_298156_1) on May 20, 2026, and is solely responsible for the information contained therein.